ADVERTISEMENT
ADVERTISEMENT

What you need to know on Wall Street right now

Hello. Here's what you need to know on Wall Street today.

Welcome to Finance Insider, Business Insider's summary of the top stories of the past 24 hours. Sign up here to get the best of Business Insider delivered direct to your inbox.

Irma ravaged the west coast of Florida and sent storm-surge flooding, tornadoes, and hurricane-force wind gusts across the state. On Monday morning, Irma was downgraded to a tropical storm, according the National Hurricane Center. But theNHC's latest updatesays the storm is still producing hurricane-strength gusts of wind and life-threatening storm surges. Here's the latest:

  • Dramatic photos show the trail of destruction Hurricane Irma is carving through Florida
  • Hurricane Irma knocks out power to 5.8 million Florida homes and businesses
  • Tesla gave some Florida vehicles a range bump so owners could escape Hurricane Irma
  • Insurance stocks are rising as Hurricane Irma damage is likely to be less than expected
ADVERTISEMENT

There's lots of Wall Street news, so here goes:

  • Goldman Sachs' head of HR is leaving
  • Citigroup is bracing for trading revenues to take a plunge
  • Goldman Sachs is planning a UK savings account for the masses — not just the super rich
  • London remains the world's top finance centre despite Brexit
  • Folger Hill, a hedge fund started by Steve Cohen's former COO, is going through a shakeup
  • HSBC has promoted 2 new heads to run its Wall Street equity capital markets business
  • A portfolio manager has returned to $42 billion hedge fund firm D.E. Shaw "at a time of strategic growth"
  • Wall Street's "compensation season" is approaching, and it's not looking good

big reasons the stock market is safe from a correction, according to Goldman Sachs. Central banks are still more important than economics or politics for asset prices, according to JPMorgan.

The creator of Wall Street's "fear gauge" says people don't understand it as well as they should. Additionally, Equifax is getting crushed — and traders are betting it's going to get so much worse.

ADVERTISEMENT

In healthcare, a new study undermines Big Pharma's justification for charging high drug prices. And the CEO of biotech Axovant, who sold his last company for $14 billion, told us why he wants to do things differently this time.

  • UBS: Here’s how Kroger can survive Amazon’s push into groceries
  • We compared Whole Food prices today to what they were two years ago — and what we found shocked us
  • Nordstrom is testing a tiny new store that doesn't sell clothes

Lastly, go inside Queen Charlotte's Ball, the glamorous, Champagne-filled event for affluent debutantes from around the world.

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng

ADVERTISEMENT
ADVERTISEMENT